Current Investments

Integrating drug discovery and cell line development with AI-enabled synthetic biology.

www.absci.com

Amber Molecular is commercializing a new class of fluorescent OLED emitters for next generation hyperfluorescence and TADF co-emission based OLED displays for consumer electronics applications.

www.ambermolecular.ca

Making painting obsolete with sustainable protective paints that heal themselves.

www.autonomicmaterials.com

Portable, ultra-wide field, imaging platform for AI-based diagnostics.

broadspotimaging.com

C3Nano is a spin out from Stanford University that is developing revolutionary transparent electrode materials for significant end market applications including flexible displays, touch screens, and solar cells.

www.c3nano.com

Chromation Inc. is commercializing an ultra-compact spectrometer for integrated and wearable applications based on proprietary Photonic Crystal technology.

www.chromation.com/

COTSWORKS designs and manufactures rugged optical components and subsystems to operate in harsh environments for applications primarily in the commercial aerospace, military, oil & gas and industrial end markets. 

www.cotsworks.com

Sustainable crop and post-harvest protection.

www.crop-enhancement.com/

Revolutionizing the composite market

www.fibrecoat.de

MIT Media Lab spinout digitizing musculoskeletal injury diagnosis and recovery.

www.figur8tech.com

Furcifer is developing the next generation of electrochromic film technology for architectural and automotive smart window applications that can be produced with roll to roll processing at a cost point which will enable widespread adoption.

www.furciferinc.com/

Sustainable, water-free, fabric finishing for apparel and footwear.

www.greenthemetek.com

Imprint Energy is commercializing a breakthrough, fully printable and rechargeable battery technology, ZincPoly, which enables ultrathin, flexible, high energy density rechargeable batteries at significantly lower cost. Imprint’s battery technology removes the design limitations and safety concerns of other battery technologies.

www.imprintenergy.com

Delivering the promise of 3D printing for mass manufacturing by additive deposition of multiple materials, AI/ML, and 3D vision.

www.inkbit3d.com

Workflow automation and data management system for life sciences, healthcare, and other industries.

www.l7informatics.com

Precision molecular diagnostic devices for at-home use.

 www.lucirahealth.com

Precision microencapsulation systems.

www.matralix.com/

Advanced gas purification systems for medical and military markets.

www.microporeusa.com/

NBD Nano is developing a suite of hydrophobic-oleophobic and water condensing coatings, additives, and surface modifying technologies that offer unprecedented durability and adaptability for numerous industrial and consumer product applications.

www.nbdnano.com/

NOHMs Technologies, Inc. is commercializing next generation Li-ion battery electrolytes based on ionic liquid technology which will enable the electric vehicle markets.

www.nohms.com/

3D spatial intelligence for transportation and monitoring.

www.oyla.ai

Measurement devices for sports analytics.

www.rapsodo.com

Engineering superior biotherapeutic formulations for fragile patients.

www.reformbiologics.com

At-line and in-line QC systems for ultra-rapid detection of microbial contamination.

www.sentinelmonitors.com/

Ultrasound technology to quantify chronic liver disease.

www.sonicincytes.com

Flywheel energy storage.

www.spinlectrix.com

Tactus Technology has developed a multi-layer polymeric film technology platform which substantially enhances key physical & optical properties of glass & digital displays.  Our TrueWrite® film creates a natural pen-on-paper writing feel and our HybridGlass® provides substantial shatter protection & enables foldable displays.

www.tactustechnology.com

Next-generation deep learning platform for drug discovery and optimization

www.valencediscovery.com

Instruments that improve patients’ sight.

www.wavefrontdynamics.com

 

Enabling contactless patient monitoring and predictive health

www.xkcorp.com

Prior Investments and Companies Founded

Pioneering microfluidics company that developed and commercialized ‘lab-on-a-chip’ technologies for use in genomics R&D and pharmaceutical drug screening.

IPO (NASDAQ: ACLA)
Acquired

Developed rapid photo-induced polymers and related process technology for manufacturing ophthalmic lenses.

Acquired / Merged by
Rodenstock GmbH

Turnkey hybrid microgrid solutions.

Acquired

Ultrasound-based downhole imaging technology.

Acquired

Mid-infrared laser sources for the life sciences, research, industrial, and defense industries.

Acquired

Manufacturers a diverse set of materials driven fiber optics components and subsystems for the telecommunications industry.

IPO (NASDAQ: FNSR) www.finisar.com

Innovative Construction and Building Materils LLC commercilaized novel gypsum-polymer technologies for lighter weight, higher strength dry-wall materials and filters.

Acquired

Metaworks Inc. The leading provider of proprietary clinical meta-analytic databases and tools that support regulatory applications and filings in the pharmaceutical industry.

Acquired by
United BioSource Corporation

Developed proprietary nanomaterials subsrates and processes for photovoltaic, optical, and electronic device product applications.

Acquired by
Teijin Ltd. (TYO:3401)

Spun out of NanoGram Corp to develop nanomaterial batteries for the medical device industry. The company’s technology enabled both higher performance and safer discharge.

Acquired by
Wilson Greatbatch Technologies, Inc. (NYSE:GB)

NanoTex developed a novel polymer technology platform for the surface modification of textiles to confer stain, odor resistance, etc. The technology was incorporated into several commercial products.

Acquired by
Burlington Industries.

A global corporation that develops and manufactures a wide range of novel photonic integrated circuit-based modules, components, and subsystems for use in optical networks.

IPO (NYSE: NPTN)
www.neophotonics.com

Develped a novel proteomics platform technology and tools for drug discovery/profiling and developed a series of novel HSP-90 inhibitors that derived from this platform for oncology indications.

Acquired by
Pfizer, Inc. (NYSE: PFE)

Animal husbandry monitoring.

Acquired

Developed a calibration -free, solid-state, non-glass based pH sensor for bioprocess, in-line process monitoring, industrial and water sensing applications.

Acquired
Undisclosed transaction

Developing non-electrical basal and bolus drug delivery technologies and devices for large and small molecules. The first product is a basal-bolus insulin pump for the Type II Diabetes market.

Privately Held
www.valeritas.com

Using machine learning and advanced immunoinformatics to identify human tissue-derived antibodies and antigens for cancer and autoimmune diseases

www.totient.bio

Developed novel gels for high performance electrical composites and cross-linkable polymers for contact lens production. The companies technologies were commercialized with several industrial partners.

Acquired / Licensed

 

VCSELs for atomic sensors and spectroscopy.
(ISIN: DE000LED4000; WKN: LED400;
trading symbol: OSR)

Acquired by
OSRAM